phosphatidylcholines has been researched along with lxt-101 in 2 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (lxt-101) | Trials (lxt-101) | Recent Studies (post-2010) (lxt-101) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 10 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Quan, D; Wang, T; Zhang, G | 1 |
| Gao, L; Li, J; Quan, D; Wang, T; Zhang, G | 1 |
2 other study(ies) available for phosphatidylcholines and lxt-101
| Article | Year |
|---|---|
Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.
Topics: Administration, Oral; Animals; Castor Oil; Castration; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Oligopeptides; Pancreatin; Pepsin A; Phosphatidylcholines; Phosphatidylglycerols; Propylene Glycol; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone | 2013 |
Oil-based formulation as a sustained-released injection for a novel synthetic peptide.
Topics: Animals; Delayed-Action Preparations; Dogs; Gonadotropin-Releasing Hormone; Hormone Antagonists; Injections; Liposomes; Male; Oleic Acid; Oligopeptides; Phosphatidylcholines; Phosphatidylglycerols; Soybean Oil; Testosterone; Triglycerides; Water | 2015 |